Iron deficiency in pulmonary arterial hypertension: perspectives
In left heart failure, iron supplementation (IS) is a first-line treatment option, regardless of anemia. Pulmonary arterial hypertension (PAH), a rare disease leading to right heart failure, is also associated with iron deficiency. While it is a much debated topic, recent evidence demonstrate that r...
Main Authors: | Marceau Quatredeniers, David Montani, Alain Cohen-Solal, Frédéric Perros |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/20458940211021301 |
Similar Items
-
Iron Deficiency in Pulmonary Arterial Hypertension: A Deep Dive into the Mechanisms
by: Marceau Quatredeniers, et al.
Published: (2021-02-01) -
An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
by: Joana Santos-Gomes, et al.
Published: (2022-07-01) -
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension
by: Frédéric Perros, et al.
Published: (2021-12-01) -
Trichloroethylene increases pulmonary endothelial permeability: implication for pulmonary veno-occlusive disease
by: Julien Caliez, et al.
Published: (2020-10-01) -
Identity crisis in pulmonary arterial hypertension
by: G. Ruffenach, et al.
Published: (2017-12-01)